- cafead   Feb 23, 2025 at 10:52: PM
via
article source
- FDA approves Mirum's Ctexli, the first treatment for cerebrotendinous xanthomatosis, a rare genetic disorder affecting fat metabolism.
- In a trial, Ctexli significantly reduced cholesterol metabolites linked to CTX, but it carries a liver toxicity warning requiring monitoring
article source